The therapeutic application of lanthanides

被引:403
作者
Fricker, SP [1 ]
机构
[1] AnorMED Inc, Biol, Langley, BC V2Z 1A6, Canada
关键词
D O I
10.1039/b509608c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The biological properties of the lanthanides, based on their similarity to calcium, have stimulated research into their therapeutic application. Historical medical uses of the lanthanides and recent advances and successes will be described in the context of the biological chemistry of lanthanides, including a new metal-based drug, lanthanum carbonate, which has recently been approved as a phosphate binder for the treatment of hyperphosphatemia. This tutorial review will be of interest to those working on metal-based drugs, including inorganic chemists, and biological scientists.
引用
收藏
页码:524 / 533
页数:10
相关论文
共 37 条
[1]   Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients [J].
Albaaj, F ;
Hutchison, AJ .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (02) :319-328
[2]   Hyperphosphataemia in renal failure - Causes, consequences and current management [J].
Albaaj, F ;
Hutchison, AJ .
DRUGS, 2003, 63 (06) :577-596
[3]   Lanthanum carbonate: a new phosphate binder [J].
Behets, GJ ;
Verberckmoes, SC ;
D'Haese, PC ;
De Broe, ME .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (04) :403-409
[4]  
BINGHAM D, 1994, BIOMETALS, V7, P142
[5]   BINDING OF LANTHANIDES TO CELL-MEMBRANES IN THE PRESENCE OF LIGANDS [J].
BINGHAM, D ;
DOBROTA, M .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1995, 59 (01) :39-52
[6]   An open study comparing topical silver sulfadiazine and topical silver sulfadiazine - cerium nitrate in the treatment of moderate and severe burns [J].
de Gracia, CG .
BURNS, 2001, 27 (01) :67-74
[7]  
Evans C.E., 1988, P1
[8]   INTERESTING AND USEFUL BIOCHEMICAL-PROPERTIES OF LANTHANIDES [J].
EVANS, CH .
TRENDS IN BIOCHEMICAL SCIENCES, 1983, 8 (12) :445-449
[9]   Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells [J].
Evens, AM ;
Lecane, P ;
Magda, D ;
Prachand, S ;
Singhal, S ;
Nelson, J ;
Miller, RA ;
Gartenhaus, RB ;
Gordon, LI .
BLOOD, 2005, 105 (03) :1265-1273
[10]   Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer [J].
Evens, AM .
CURRENT OPINION IN ONCOLOGY, 2004, 16 (06) :576-580